Boundless Bio Inc [BOLD] stock prices are up 6.82% to $1.41 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The BOLD shares have gain 10.16% over the last week, with a monthly amount glided 23.68%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Boundless Bio Inc [NASDAQ: BOLD] stock has seen the most recent analyst activity on June 02, 2025, when H.C. Wainwright initiated its Buy rating and assigned the stock a price target of $5. Previously, Leerink Partners downgraded its rating to Market Perform on May 28, 2025, and kept the price target unchanged to $3. On December 13, 2024, downgrade downgraded it’s rating to Neutral. Piper Sandler started tracking the stock assigning a Overweight rating and suggested a price target of $20 on April 22, 2024. Leerink Partners initiated its recommendation with a Outperform and recommended $25 as its price target on April 22, 2024. Guggenheim started tracking with a Buy rating for this stock on April 22, 2024, and assigned it a price target of $24.
The stock price of Boundless Bio Inc [BOLD] has been fluctuating between $1.00 and $3.75 over the past year. Boundless Bio Inc [NASDAQ: BOLD] shares were valued at $1.41 at the most recent close of the market.
Analyzing the BOLD fundamentals
Gross Profit Margin for this corporation currently stands at -0.35% with Operating Profit Margin at -67.61%, Pretax Profit Margin comes in at -60.98%, and Net Profit Margin reading is -60.98%. To continue investigating profitability, this company’s Return on Assets is posted at -0.36, Equity is -0.45 and Total Capital is -0.42. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.4.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.3200 points at the first support level, and at 1.2300 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.4800, and for the 2nd resistance point, it is at 1.5500.
Ratios To Look Out For
It’s worth pointing out that Boundless Bio Inc [NASDAQ:BOLD]’s Current Ratio is 14.08. On the other hand, the Quick Ratio is 14.08, and the Cash Ratio is 1.6.
